McKinsey Says Purdue Ch. 11 Plan Endangers Sackler Claims

By Emily Lever · June 12, 2025, 3:21 PM EDT

McKinsey & Co. has asked a New York bankruptcy judge to reject the disclosure statement for Purdue Pharma's Chapter 11 plan, saying there is ambiguity on how the plan will deal with...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Objection

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Emily

June 12, 2025
Auto Parts Co. Marelli Can Tap $519M In Ch. 11 Financing
June 11, 2025
KKR-Backed Auto Parts Co. Blames Tariffs For $4.9B Ch. 11
June 10, 2025
Farella Braun Wins Partial Fee Award In FDIC Dispute
June 09, 2025
Rhodium Funders Go After Ch. 11 Plan Exclusivity
June 06, 2025
Brazilian Airline Azul's $3B Path To A Ch. 11 In NY
June 05, 2025
Gol Linhas Can Implement Ch. 11 Plan With Releases
June 04, 2025
Judge Grills Kidde-Fenwal About Missing Info In Disclosures
June 03, 2025
US Trustee Says Conn's Ch. 11 Plan's Releases Are Improper
June 02, 2025
23andMe Founder Pushes Alternative Ch. 11 Sale
May 30, 2025
Parents Bail Out Bankrupt Private School In Manhattan